|
National Stock Number(NSN): 6505-01-381-0221 (6505013810221, 013810221)
| NIIN: |
01-381-0221 |
Item Name: |
CEFOTETAN DISODIUM,STERILE,USP |
INC: |
77777 |
| FSC: |
6505
|
Assignment Date: |
Oct-05-1993 |
CRIT: |
X |
IIG: |
77777 |
| ISC: |
2 |
Date Standardized: |
Oct-05-1993 |
HMIC: |
Y |
DODIC: |
|
| NSC: |
8 |
Cancellation Date: |
Apr-30-2010 |
PMIC: |
A |
FIIG: |
A23900 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
4 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
1 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
ADD-VANTAGE |
13992
|
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
CEFOTAN |
13992
|
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
L93-388 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00038-0377-32 |
13992
|
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS |
H |
5 |
9 |
4 |
ZZ |
|
B |
|
|
|
|
|
NDC00310-0377-32 |
13992
|
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
Y |
|
M |
U |
1 |
A |
$2,867.60 |
PG |
|
C2201X- |
Mar-01-2002 |
H |
| DF |
S9M |
H |
|
M |
U |
1 |
F |
$2,867.60 |
PG |
|
------- |
Oct-01-2001 |
H |
| DN |
S9M |
Y |
|
M |
U |
1 |
N |
$2,867.60 |
PG |
|
9L----- |
Dec-01-2001 |
H |
| DS |
S9M |
H |
|
M |
U |
1 |
D |
$2,867.60 |
PG |
|
------- |
Oct-01-2001 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 100EA |
000 |
|
|
|
| DA |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 100EA |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 100EA |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 100EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| TEXT |
GENERAL CHARACTERISTICS ITEM DESCRIPTION |
2 GRAMS CEFOTETAN DISODIUM; POWDER; INTRAVENOUS; ADD-VANTAGE VIAL AND FLEXIBLE DILUENT CONTAINER; 100 PER PKG; THERAPEUTIC EQUIVALENT TO CEFOTAN BY STUART PHARMACEUTICALS |
|